SYNVICHOR
LIVE

Serial Number

79299298

Owner

OrthoDx Pty Ltd

Attorney

Rebecca E. McDougall

Filing Date

Sep 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SYNVICHOR Trademark

Serial Number: 79299298 • Registration: 6585415

SYNVICHOR is a trademark filed by OrthoDx Pty Ltd on September 3, 2020. The trademark is classified under Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

OrthoDx Pty Ltd (3 trademarks)

Suite 300, Level 3
Wetherill Park, NSW 2164 , AU

Entity Type: 82

Trademark Details

Filing Date

September 3, 2020

Registration Date

December 14, 2021

Published for Opposition

September 28, 2021

Goods & Services

Medical diagnostic testing, monitoring and reporting services including providing information, reports, testing and analysis relating to inflammation and infection in the body; medical testing services in the field of testing for inflammation and infection in the body, design and development of medical diagnostic kits for others; provision of medical information and support in the nature of medical consulting and advisory services in the field of inflammation and infection; medical genomic diagnostic testing, monitoring and reporting services; information, advisory and consultancy services in relation to the aforementioned

Medical diagnostic device including to differentiate inflammation and infection in the body including joints, namely, medical diagnostic apparatus for testing and differentiating between joint inflammation and infection; medical analysis instrument and apparatus, namely, medical analysis instrument and apparatus for testing and differentiating between joint inflammation and infection; medical apparatus for diagnostic, detection, monitoring, measuring, testing and analysis purposes, namely, medical apparatus for diagnosing, detecting, monitoring, measuring, testing and analysing joint inflammation and infection; medical diagnostic testing apparatus, screening kits in this class for the detection and diagnosis of inflammation and infection in the body, namely, medical diagnostic testing apparatus and screening kit comprised of medical diagnostic apparatus for testing, detecting and differentiating sterile inflammatory joint pain from non-infective joint pain for detecting, diagnosing, testing and differentiating between joint inflammation and infection; orthopaedic apparatus inducing to diagnose inflammation and infection, namely, medical orthopaedic apparatus for testing, diagnosing and differentiating between joint inflammation and infection; biomarker diagnostic device being medical biomarker diagnostic apparatus for testing biomarkers to differentiate between joint inflammation and infection; genomic diagnostic device being medical genomic diagnostic apparatus for genomic testing to differentiate between joint inflammation and infection; medical diagnostic device being medical diagnostic apparatus for testing and differentiating between joint inflammation and infection for use in general, orthopaedic, renal, paediatric, neurological, trauma and other medical devices

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
May 23, 2023 NURC
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 20, 2023 APRE
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 20, 2023 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 19, 2023 APRE
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 21, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 27, 2022 FICS
FINAL DISPOSITION PROCESSED
May 27, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 14, 2022 FICR
TEAS SECTION 7 REQUEST RECEIVED
Jan 21, 2022 ES7R
REGISTERED-PRINCIPAL REGISTER
Dec 14, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 28, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 28, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 8, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 23, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 23, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 23, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 23, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 29, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 29, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 29, 2021 TROA
CORRECTION SENT TO IB
Mar 1, 2021 CRSN
CORRECTION CREATED FOR IB
Mar 1, 2021 CRCR
REFUSAL PROCESSED BY IB
Feb 21, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 3, 2021 RFCS
REFUSAL PROCESSED BY MPU
Feb 3, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 16, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jan 15, 2021 CNRT
ASSIGNED TO EXAMINER
Jan 11, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 8, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 4, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 3, 2020 REPR